CU23334A1 - Vacuna de vibrio cholerae inactivada en tabletas - Google Patents
Vacuna de vibrio cholerae inactivada en tabletasInfo
- Publication number
- CU23334A1 CU23334A1 CU20030061A CU20030061A CU23334A1 CU 23334 A1 CU23334 A1 CU 23334A1 CU 20030061 A CU20030061 A CU 20030061A CU 20030061 A CU20030061 A CU 20030061A CU 23334 A1 CU23334 A1 CU 23334A1
- Authority
- CU
- Cuba
- Prior art keywords
- vibrio cholerae
- vaccine
- inactivated
- tablets
- vaccines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/107—Vibrio
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K2039/106—Vibrio; Campylobacter; Not used, see subgroups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invencion se relaciona con el campo de las vacunas, específicamente con las vacunas de aplicacion oral contra el colera. El objetivo tÉcnico que persigue es obtener una formulacion en tabletas de vacunas de cÉlulas enteras inactivadas de Vibrio cholerae. La invencion describe la formulacion del producto vacunal.
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20030061A CU23334A1 (es) | 2003-03-20 | 2003-03-20 | Vacuna de vibrio cholerae inactivada en tabletas |
PE2004000270A PE20041064A1 (es) | 2003-03-20 | 2004-03-12 | Vacuna de vibrio cholerae inactivada en tabletas |
ARP040100865A AR043621A1 (es) | 2003-03-20 | 2004-03-16 | Vacuna de vibrio cholerae inactivada en tabletas |
EP04721813A EP1614427A1 (en) | 2003-03-20 | 2004-03-19 | Inactivated vibrio cholerae vaccine in tablet form |
KR1020057016763A KR20050109978A (ko) | 2003-03-20 | 2004-03-19 | 비활성화된 비브리오 콜레라 백신 타블렛 |
PCT/CU2004/000005 WO2004082711A1 (es) | 2003-03-20 | 2004-03-19 | Vacuna de vibrio cholerae inactivada en tabletas |
US10/549,992 US20060246094A1 (en) | 2003-03-20 | 2004-03-19 | Inactivated vibrio cholerae vaccine in tablet form |
CA002519225A CA2519225A1 (en) | 2003-03-20 | 2004-03-19 | Inactivated vibrio cholerae vaccine in tablet form |
JP2006504217A JP2006520332A (ja) | 2003-03-20 | 2004-03-19 | 錠剤状の不活化コレラ菌ワクチン |
BRPI0408409-8A BRPI0408409A (pt) | 2003-03-20 | 2004-03-19 | composição de vacina contra o cólera |
CNA2004800135037A CN1791426A (zh) | 2003-03-20 | 2004-03-19 | 片剂形式的灭活的霍乱弧菌疫苗 |
EC2005005997A ECSP055997A (es) | 2003-03-20 | 2005-09-02 | Vacuna de vibrio cholerae inactivada en tabletas |
ZA200507576A ZA200507576B (en) | 2003-03-20 | 2005-09-19 | Inactivated Vibrio cholerae vaccine in tablet form |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20030061A CU23334A1 (es) | 2003-03-20 | 2003-03-20 | Vacuna de vibrio cholerae inactivada en tabletas |
Publications (1)
Publication Number | Publication Date |
---|---|
CU23334A1 true CU23334A1 (es) | 2008-12-24 |
Family
ID=40203015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CU20030061A CU23334A1 (es) | 2003-03-20 | 2003-03-20 | Vacuna de vibrio cholerae inactivada en tabletas |
Country Status (13)
Country | Link |
---|---|
US (1) | US20060246094A1 (es) |
EP (1) | EP1614427A1 (es) |
JP (1) | JP2006520332A (es) |
KR (1) | KR20050109978A (es) |
CN (1) | CN1791426A (es) |
AR (1) | AR043621A1 (es) |
BR (1) | BRPI0408409A (es) |
CA (1) | CA2519225A1 (es) |
CU (1) | CU23334A1 (es) |
EC (1) | ECSP055997A (es) |
PE (1) | PE20041064A1 (es) |
WO (1) | WO2004082711A1 (es) |
ZA (1) | ZA200507576B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2616912T3 (es) * | 2009-09-16 | 2017-06-14 | Msd Wellcome Trust Hilleman Laboratories Pvt Ltd. | Vacuna contra la diarrea debida a E. coli enterotoxigénica (ETEC) y el cólera |
MY190074A (en) * | 2018-01-09 | 2022-03-24 | Aimst Univ | A monovalent vaccine formulation and a method for preparation thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62502262A (ja) * | 1985-03-27 | 1987-09-03 | ブロンコスタット・プロプライアタリー・リミテツド | アジユバントを含有しないワクチン |
US4871546A (en) * | 1987-06-29 | 1989-10-03 | Sandoz Pharm. Corp. | Gastrointestinal protective coating formulations |
IT1260505B (it) * | 1992-06-01 | 1996-04-09 | Poli Ind Chimica Spa | Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon |
US6203799B1 (en) * | 1993-07-01 | 2001-03-20 | Presidents And Fellows Of Harvard College | Vibrio cholerae mutants which are soft-agar penetration defective and lack a functional CtxA subunit |
-
2003
- 2003-03-20 CU CU20030061A patent/CU23334A1/es unknown
-
2004
- 2004-03-12 PE PE2004000270A patent/PE20041064A1/es not_active Application Discontinuation
- 2004-03-16 AR ARP040100865A patent/AR043621A1/es not_active Application Discontinuation
- 2004-03-19 BR BRPI0408409-8A patent/BRPI0408409A/pt not_active IP Right Cessation
- 2004-03-19 CA CA002519225A patent/CA2519225A1/en not_active Abandoned
- 2004-03-19 CN CNA2004800135037A patent/CN1791426A/zh active Pending
- 2004-03-19 JP JP2006504217A patent/JP2006520332A/ja active Pending
- 2004-03-19 US US10/549,992 patent/US20060246094A1/en not_active Abandoned
- 2004-03-19 KR KR1020057016763A patent/KR20050109978A/ko not_active Application Discontinuation
- 2004-03-19 EP EP04721813A patent/EP1614427A1/en not_active Withdrawn
- 2004-03-19 WO PCT/CU2004/000005 patent/WO2004082711A1/es not_active Application Discontinuation
-
2005
- 2005-09-02 EC EC2005005997A patent/ECSP055997A/es unknown
- 2005-09-19 ZA ZA200507576A patent/ZA200507576B/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2006520332A (ja) | 2006-09-07 |
PE20041064A1 (es) | 2005-03-02 |
CN1791426A (zh) | 2006-06-21 |
CA2519225A1 (en) | 2004-09-30 |
ECSP055997A (es) | 2006-01-27 |
EP1614427A1 (en) | 2006-01-11 |
BRPI0408409A (pt) | 2006-03-21 |
US20060246094A1 (en) | 2006-11-02 |
WO2004082711A1 (es) | 2004-09-30 |
AR043621A1 (es) | 2005-08-03 |
KR20050109978A (ko) | 2005-11-22 |
ZA200507576B (en) | 2007-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2019000209A1 (es) | Formulación novedosa administrable por la vía oral. | |
CY1121107T1 (el) | Φαρμακοτεχνικες μορφες δισκιων αμεσης απελευθερωσης | |
ECSP066826A (es) | Inhibidores de integrasa de vih | |
UY31350A1 (es) | (carboxilalquilenfenil)feniloxamidas, procedimiento para su preparación y su utilización como medicamentos | |
MY157661A (en) | Bendamustine pharmaceutical compositions | |
AR054188A1 (es) | Aminas ciclicas con actividad inhibitoria del factor de coagulacion xa, metodos para su sintesis, intermediarios del proceso de obtencion de las mismas y su elaboracion, composiciones farmaceuticas que las contienen y su uso en la preparacion de medicamentos para el tratamiento de enfermedades del a | |
AR060130A1 (es) | Formulacion de un anticuerpo monoclonal humano anti- igf-1r | |
CO6480932A2 (es) | Antagonistas de la trayectoria hedgehog de ftalazina disustituida. | |
CR20120289A (es) | Derivados de dioxa-biciclo[3.2.1]octano-2,3,4-triol | |
NI202000007A (es) | Gel que comprende clorhexidina | |
TW200700062A (en) | Pharmaceutical compositions | |
NO20084478L (no) | Konjugerte lipidderivater | |
CL2008002394A1 (es) | Depsipeptido ciclico, o derivados, inhibidores de calicreína 7, obtenidos desde chondromyces crocatus, metodo de obtencion y usos terapeuticos. | |
UA99645C2 (ru) | Гель, имеющий противовоспалительное и противоаллергическое действие | |
UY32190A (es) | Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibdores de quinasas dependientes de ciclina (cdk), produccion y uso de los mismos como productos medicinales | |
CR20150266A (es) | Formulaciones de liberación modificada para oprozomib | |
CO6420389A2 (es) | Composiciones y métodos para el tratamiento y prevención de la enfermedad cardiovascular | |
ATE452120T1 (de) | Fettsäure-benzenediol-derivate sowie herstellungs-und verwendungsverfahren dafür | |
UA96794C2 (ru) | Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе | |
CL2010000281A1 (es) | Formulacion oral en forma de tableta de 9-[(2,2-dimetil-propilamino)-metil]-minociclina; metodo de preparacion; formulacion inyectable del mismo; utiles en el tratamiento de una infeccion. | |
ATE526015T1 (de) | Arzneimittel sowie deren herstellung und verwendung bei der behandlung von schmerzhaften neuropathien | |
AR103648A1 (es) | Terapia de combinación contra el cáncer | |
ECSP055997A (es) | Vacuna de vibrio cholerae inactivada en tabletas | |
BRPI0416188A (pt) | formulações de medicamentos que contêm aromatizante, com propriedades farmacêuticas aperfeiçoadas | |
BRPI0408848B8 (pt) | composições farmacêuticas de complexo de ciclodextrina-cladribina complexo, usos do referido complexo, bem como processos para a sua preparação |